HIV self-test kits combined with financial incentives may encourage men to attend the clinic for post-test HIV services.
More black index patients diagnosed with HIV are interviewed for partner services than all index patients combined.
Growing evidence supports starting individuals on antiretroviral therapy as soon as they are diagnosed with HIV to improve mortality rates.
Increased-risk donors significantly more likely to have positive HBV, HCV screening results.
Risk greatest with higher-dose opioids and opioids with immunosuppressive properties.
Depression is a common comorbidity in people living with HIV, with lifetime prevalence estimates ranging from 22% to 61%.
Investigators sought to determine the association between liver fibrosis and hepatitis B virus genotype G in patients with comorbid HIV and HBV.
A 44-year-old man presents to the hospital with generalized abdominal pain, malaise, subjective low-grade fever, and a bruise on his left shin. He has an extensive medical history including HIV, hypertension, diabetes, and GERD, but he denies vomiting or diarrhea.
HIV-exposed infants have high rates of congenital cCMV infection, and in utero HIV infection seems to be a major risk factor for cCMV.
HIV-infected Hispanics have an increased risk for human papillomavirus-related cancers than Hispanics in the general population.
Family-centered pediatric advance care planning is associated with a lower likelihood of symptoms and suffering for adolescents with HIV.
Seven percent of those with indications for PrEP were prescribed PrEP, including 2.1% of women.
Analysis of 2 phase 3 clinical trials evaluating the safety/efficacy of glecaprevir/pibrentasvir in people with HCV coinfected with HIV-1 found an overall sustained virologic response of 98% at week 12 of treatment in those with or without cirrhosis.
A combination single tablet once-a-day regimen of doravirine/lamivudine/tenofovir disoproxil fumarate demonstrated non-inferiority and no significant adverse events when compared with continuation of established antiretroviral therapy in adults infected with HIV-1.
Number of HIV diagnoses in those aged 13 to 29 4x higher than those aged 50 years.
Inspection at the VIP Spa in Albuquerque detected practices that might spread HIV or hepatitis B and C.
Delstrigo is approved as a complete regimen whereas Pifeltro is to be administered in combination with other antiretrovirals.
Compared with uninfected individuals, people with HIV controlled with combination antiretroviral therapy are not at increased risk of developing thyroid dysfunction.
Patient navigation may be considered an effective strategy to enhance engagement and continuation in disease treatment among people with HIV.
Lower odds of having detectable viral load for older adults and those using ISTI-based regimen.